Literature DB >> 18693086

Dopamine and serotonin levels following prenatal viral infection in mouse--implications for psychiatric disorders such as schizophrenia and autism.

Christine Winter1, Teri J Reutiman, Timothy D Folsom, Reinhard Sohr, Rainer J Wolf, Georg Juckel, S Hossein Fatemi.   

Abstract

Prenatal viral infection has been associated with neurodevelopmental disorders such as schizophrenia and autism. It has previously been demonstrated that viral infection causes deleterious effects on brain structure and function in mouse offspring following late first trimester (E9) and middle-late second trimester (E18) administration of influenza virus. Neurochemical analysis following infection on E18 using this model has revealed significantly altered levels of serotonin, 5-hydroxyindoleacetic acid, and taurine, but not dopamine. In order to monitor these different patterns of monoamine expression in exposed offspring in more detail and to see if there are changes in the dopamine system at another time point, pregnant C57BL6J mice were infected with a sublethal dose of human influenza virus or sham-infected using vehicle solution on E16. Male offspring of the infected mice were collected at P0, P14, and P56, their brains removed and cerebellum dissected and flash frozen. Dopamine and serotonin levels were then measured using HPLC-ED technique. When compared to controls, there was a significant decrease in serotonin levels in the cerebella of offspring of virally exposed mice at P14. No differences in levels of dopamine were observed in exposed and control mice, although there was a significant decrease in dopamine at P14 and P56 when compared to P0. The present study shows that the serotonergic system is disrupted following prenatal viral infection, potentially modelling disruptions that occur in patients with schizophrenia and autism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18693086      PMCID: PMC2714699          DOI: 10.1016/j.euroneuro.2008.06.001

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  31 in total

Review 1.  The specificity of neurological signs in schizophrenia: a review.

Authors:  M P Boks; S Russo; R Knegtering; R J van den Bosch
Journal:  Schizophr Res       Date:  2000-06-16       Impact factor: 4.939

Review 2.  Review of immunological and immunopathological findings in schizophrenia.

Authors:  M Rothermundt; V Arolt; T A Bayer
Journal:  Brain Behav Immun       Date:  2001-12       Impact factor: 7.217

3.  Prefrontal dopamine D1 receptors and working memory in schizophrenia.

Authors:  Anissa Abi-Dargham; Osama Mawlawi; Ilise Lombardo; Roberto Gil; Diana Martinez; Yiyun Huang; Dah-Ren Hwang; John Keilp; Lisa Kochan; Ronald Van Heertum; Jack M Gorman; Marc Laruelle
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

4.  Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia.

Authors:  S Hossein Fatemi; Julie Earle; Reena Kanodia; David Kist; Effat S Emamian; Paul H Patterson; Limin Shi; Robert Sidwell
Journal:  Cell Mol Neurobiol       Date:  2002-02       Impact factor: 5.046

Review 5.  Role of altered brain serotonin mechanisms in autism.

Authors:  D C Chugani
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

Review 6.  The role of the cerebellum in schizophrenia.

Authors:  Nancy C Andreasen; Ronald Pierson
Journal:  Biol Psychiatry       Date:  2008-04-08       Impact factor: 13.382

7.  Serologic evidence of prenatal influenza in the etiology of schizophrenia.

Authors:  Alan S Brown; Melissa D Begg; Stefan Gravenstein; Catherine A Schaefer; Richard J Wyatt; Michaeline Bresnahan; Vicki P Babulas; Ezra S Susser
Journal:  Arch Gen Psychiatry       Date:  2004-08

Review 8.  Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia.

Authors:  Henry Silver
Journal:  Expert Opin Pharmacother       Date:  2004-10       Impact factor: 3.889

9.  Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring.

Authors:  Limin Shi; S Hossein Fatemi; Robert W Sidwell; Paul H Patterson
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

10.  Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity.

Authors:  Georg Juckel; Jürgen Gallinat; Michael Riedel; Safet Sokullu; Carl Schulz; Hans-Jürgen Möller; Norbert Müller; Ulrich Hegerl
Journal:  Schizophr Res       Date:  2003-11-15       Impact factor: 4.939

View more
  33 in total

Review 1.  Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues.

Authors:  Luke E Grzeskowiak; Andrew L Gilbert; Janna L Morrison
Journal:  Drug Saf       Date:  2011-11-01       Impact factor: 5.606

Review 2.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

3.  A classification of sociomedical health indicators: perspectives for health administrators and health planners.

Authors:  A E Siegmann
Journal:  Int J Health Serv       Date:  1976       Impact factor: 1.663

4.  The effects of prenatal H1N1 infection at E16 on FMRP, glutamate, GABA, and reelin signaling systems in developing murine cerebellum.

Authors:  S Hossein Fatemi; Timothy D Folsom; Stephanie B Liesch; Rachel E Kneeland; Mahtab Karkhane Yousefi; Paul D Thuras
Journal:  J Neurosci Res       Date:  2016-10-13       Impact factor: 4.164

5.  Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disorders.

Authors:  Demian Obregon; Ellisa Carla Parker-Athill; Jun Tan; Tanya Murphy
Journal:  Neuropsychiatry (London)       Date:  2012-08

6.  Altered cerebellar organization and function in monoamine oxidase A hypomorphic mice.

Authors:  Loai Alzghoul; Marco Bortolato; Foteini Delis; Panayotis K Thanos; Ryan D Darling; Sean C Godar; Junlin Zhang; Samuel Grant; Gene-Jack Wang; Kimberly L Simpson; Kevin Chen; Nora D Volkow; Rick C S Lin; Jean C Shih
Journal:  Neuropharmacology       Date:  2012-08-16       Impact factor: 5.250

7.  Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia.

Authors:  Yael Piontkewitz; Michal Arad; Ina Weiner
Journal:  Schizophr Bull       Date:  2010-05-03       Impact factor: 9.306

Review 8.  The serotonin system in autism spectrum disorder: From biomarker to animal models.

Authors:  C L Muller; A M J Anacker; J Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

9.  Animal models of virus-induced neurobehavioral sequelae: recent advances, methodological issues, and future prospects.

Authors:  Marco Bortolato; Sean C Godar
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-05-18

10.  Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging.

Authors:  Hanna Jaaro-Peled; Minae Niwa; Catherine A Foss; Rina Murai; Samantha de Los Reyes; Atsushi Kamiya; Yolanda Mateo; Patricio O'Donnell; Nicola G Cascella; Toshitaka Nabeshima; Tomás R Guilarte; Martin G Pomper; Akira Sawa
Journal:  Hum Mol Genet       Date:  2013-01-11       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.